•  
  •  
  •  
  •  

2025-12-06 21:57:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • RailTel Corporation of India Ltd receives LOA for order worth Rs. 14.40 crores
  • Capital Trade Links Ltd enters into MOU with CER Rooftop Pvt Ltd
  • ARCL Organics Ltd signs MOU for land, asset purchase
  • Takyon Networks Ltd receives order from Hindustan Aeronautics Ltd, Kanpur
  • Excelsoft and AQA Announce Joint AI Taskforce to research Advanced Ethical and Secure AI for E-Marking of Handwritten Student Responses

Keywords Selected:  SunPharmaceuticalIndustries

Stock Report

  • Sun Pharma Laboratories Ltd to set up greenfield formulations facility in MP
  • Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
  • AstraZeneca Pharma India Ltd and Sun Pharma partner to help patients living with Hyperkalaemia in India
  • Philogen provides update on Fibromun clinical study developments
  • Sun Pharmaceutical Industries Ltd consolidated Q2FY26 PAT increases to Rs. 3137.09 crores
  • Update on US FDA Inspection at Sun Pharma Halol Facility
  • Sun Pharmaceutical Industries Ltd group has signed settlement agreement in the In re Generic Pharmaceuticals Pricing Antitrust Litigation
  • Sun Pharma's Phase 3 Clinical Studies Evaluating Tildrakizumab 100 mg in Active Psoriatic Arthritis Meet their Primary Endpoint
  • Philogen provides update on Marketing Authorization application for Nidlegy™ in the European Union
  • Sun Pharma appoints Kirti Ganorkar as the MD, Dilip Shanghvi to continue as the Executive Chairman of the Board
  • Sun Pharma gets 8 observations from USFDA for Halol facility
  • Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
  • Order Vacating Preliminary Injunction on LEQSELVI™
  • Sun Pharma introduces a novel class of drug, Fexuclue® in India for treatment of Erosive Esophagitis
  • Sun Pharma to acquire Checkpoint Therapeutics
  • Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
  • Sun Pharma introduces a novel treatment, STARIZO in India for acute bacterial skin and skin structure infections
  • Sun Pharmaceutical Industries Ltd posts consolidated PAT of Rs. 2835.62 crores
  • Submission of Nidlegy™ Marketing Authorization Application Validated by EMA
  • Sun Pharma Completes Taro Merger
  • Sun Pharmaceutical Industries Ltd receives warning letter from USFDA for Dadra facility
  • Sun Pharma and Moebius Medical Ltd present Phase 2b study on MM-II
  • Sun Pharma to acquire stake in HaystackAnalytics Pvt Ltd
  • Nidlegy™ Marketing Authorization Application Submitted to EMA

Latest Post

  • RailTel Corporation of India Ltd receives LOA for order worth Rs. 14.40 crores
  • Capital Trade Links Ltd enters into MOU with CER Rooftop Pvt Ltd
  • ARCL Organics Ltd signs MOU for land, asset purchase
  • Takyon Networks Ltd receives order from Hindustan Aeronautics Ltd, Kanpur
  • Excelsoft and AQA Announce Joint AI Taskforce to research Advanced Ethical and Secure AI for E-Marking of Handwritten Student Responses


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024